Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers

NCT02305277 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson

Interventions

DRUG: BIA 9-1067 (clinical micronized, CM)
DRUG: BIA 9-1067 (to-be-marketed, TBM)

Sponsor

Bial - Portela C S.A.